Krishnan K A, Sluss P M, Reichert L E
J Androl. 1986 Jan-Feb;7(1):42-8. doi: 10.1002/j.1939-4640.1986.tb00865.x.
Purification of low Mr (less than 5000) inhibitors of FSH binding to receptors has been hampered by their low concentration in tissue extracts and physiologic fluids. The calf testis represents an accessible and economic source of large quantities of tissue, and was therefore studied as a source of FSH binding inhibitors. Supernatants (27,000 X g) of calf testis homogenates inhibited binding of [125I]-hFSH as well as [125I]-hCG to membrane-bound receptor from the same source. FSH binding inhibitor was concentrated from large volumes of testis supernatant by precipitation of inert material with metaphosphoric acid, concentration/desalting of the resulting supernatant by ultrafiltration (Amicon UM-05 membranes) and lyophilization. Separation of FSH binding inhibitor and LH(hCG) binding inhibitor activities could be achieved by molecular sieving on Sephadex G-25. A partially purified fraction with inhibitors of FSH binding activity (ED50 = 44 micrograms protein) and free of LH(hCG) binding inhibitor activity (no activity at 800 micrograms protein) emerged with a Ve/Vo of 1.9, reflecting an apparent Mr of about 1500. Inhibitors of LH(hCG) binding activity emerged with the column outer volume. Rechromatography of the FSH binding inhibitor fraction on G-25 indicated two closely associated peaks of activity. These could be further resolved by gel filtration through BioGel P2, to give a salt-free fraction with an FSH binding inhibitor activity (ED50) of 24 micrograms protein. The inhibitor was heat-labile, losing 80% of its activity after 2 hours at 100 C. The testicular low molecular weight FSH binding inhibitor is similar to bovine follicular fluid and serum FSH binding inhibitor by several parameters.(ABSTRACT TRUNCATED AT 250 WORDS)
低分子量(小于5000)的促卵泡激素(FSH)与受体结合抑制剂在组织提取物和生理体液中的浓度很低,这阻碍了对其的纯化。小牛睾丸是大量组织的一个可获取且经济的来源,因此被作为FSH结合抑制剂的来源进行研究。小牛睾丸匀浆的上清液(27,000×g)可抑制[125I] - 人促卵泡激素(hFSH)以及[125I] - 人绒毛膜促性腺激素(hCG)与来自同一来源的膜结合受体的结合。通过用偏磷酸沉淀惰性物质、用超滤(Amicon UM - 05膜)对所得上清液进行浓缩/脱盐以及冻干,从大量睾丸上清液中浓缩FSH结合抑制剂。通过在葡聚糖凝胶G - 25上进行分子筛可实现FSH结合抑制剂和促黄体生成素(LH)(hCG)结合抑制剂活性的分离。一个具有FSH结合活性抑制剂(半数有效剂量(ED50)= 44微克蛋白质)且无LH(hCG)结合抑制剂活性(800微克蛋白质时无活性)的部分纯化级分以洗脱体积与柱床体积之比(Ve/Vo)为1.9出现,这表明其表观分子量约为1500。LH(hCG)结合活性抑制剂在柱外体积处出现。FSH结合抑制剂级分在G - 25上的再层析显示出两个紧密相关的活性峰。通过BioGel P2凝胶过滤可进一步将它们分离,得到一个无盐级分,其FSH结合抑制剂活性(ED50)为24微克蛋白质。该抑制剂对热不稳定,在100℃下2小时后失去80%的活性。通过几个参数来看,睾丸中的低分子量FSH结合抑制剂与牛卵泡液和血清FSH结合抑制剂相似。(摘要截短于250词)